Research - NCI-CONNECTions
Rare brain and spine tumor research news and updates from NCI leading experts and collaborators. Includes articles on molecular profiling, genetic testing, and clinical studies and trials to develop better therapies.
-
An interim study analysis demonstrates that combining Fitbit data with self-assessments is a reliable method for understanding sleep changes in patients.
-
A phase 1/2 clinical trial is testing an investigational drug called PLX038 on hard-to-treat central nervous system tumors containing extra copies of the MYC and MYCN genes.
-
A new study explores how non-medical factors influence the neurocognitive and mood-related symptoms that people with brain tumors experience. These factors include gender or sex, education, where people live, and more.
-
The new analyses reveal critical information that will help providers and researchers understand the unique needs of these patients.
-
A new trial investigates zotiraciclib as a treatment for people with recurrent gliomas containing an IDH1 or IDH2 mutation to control tumor growth and improve quality of life.
-
In a new systematic review, researchers identify the specific challenges that make it difficult for this patient population to enroll in clinical trials and seek specialized treatment.
-
Researchers share up-to-date trends in brain and spine tumor incidence, prevalence, and survival that incorporate new classification standards.
-
Dr. Terri Armstrong joined fellow leaders in the field of cancer survivorship to discuss the needs of those living with brain and spine tumors, as well as goals for the future and research funding opportunities.
-
Dr. Byram Ozer joins NCI-CONNECT to help care for and educate patients, while bringing together medical professionals to learn new skills and treatment approaches.
-
In the six years since it began, the Natural History Study has amassed an enormous database of information that is helping to improve treatment and quality of life for patients with rare central nervous system cancers.